Health Canada approved Lilly’s $47,250 Alzheimer’s drug Kisunla, raising new questions over public reimbursement.

Health Canada has approved donanemab, the country’s second disease-modifying Alzheimer’s drug for early-stage patients, while UK researchers announced a home-based finger-prick test to help assess ...

A new study from the Alzheimer Society of Canada is ringing alarm bells about the increasing number of people dealing with dementia. Called "The Landmark Study: The Many Faces of Dementia in Canada," ...

ST. LOUIS--(BUSINESS WIRE)--People in Canada concerned about their memory loss or their loved ones’ issues now have a new option to aid in diagnosis. Toronto Memory Program (TMP) is the first clinic ...

NKGen Biotech activates two new clinical trial sites for Alzheimer's treatment, enhancing patient access and recruitment for troculeucel therapy. NKGen Biotech, Inc. has announced the activation of ...

The Alzheimer Society of Cornwall and District (ASCD) has launched a new, paired support group program. The DUO support group ...